Occupational exposure to blood and body fluids among nursing studentshv in clinical internship

Background

During their academic activities, nursing students are required to carry out clinical internships during which they can be exposed to contamination by bloodborne pathogens. Objective. The study was carried out to determine the prevalence and associated factors of occupational exposure to biological material potentially infected by blood in a population of nursing students.

Materials and Methods

A cross-sectional design was used in this study and a self-administered questionnaire was provided to students. The research work was conducted from February 20, 2022, to March 15, 2022.

Results

The questionnaire was completed by 119 students. A total of 94 (78.99%) of the participants were female with a mean age of 20.46±1.16 years. 48 (40.34%) exposures were recorded with corresponding incidence rates of 0.4 exposures/person/year. With at least one accidental exposure to blood in 21 (43.75%) students. The OR analysis made by year of study showed that the ratio between the exposure risk was lower than 1 with P>0.05. The comparison between the different nursing specialties showed a significant difference between the students of General Nurses and Family and Community Health Nurses. The variables associated with exposures to blood were: female sex and personal protective equipment.

Conclusions

During their clinical training, nursing students face several types of risks including biological through blood. In order to prevent the occurrence of these incidents, the consequences of which can be fatal, it is necessary to invest in training sessions and our institute should set up a local management unit for following the exposed students.

AMSSM Position Statement Update: Blood-Borne Pathogens in the Context of Sports Participation

This AMSSM position statement update is directed toward health care providers of patients involved in sport and exercise. There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), and this update incorporates these advancements. This document is intended as a general guide to clinical practice based on the current state of evidence, while acknowledging the need for modification as new knowledge becomes available. Confirmed transmission of BBPs during sport is exceedingly rare. There are no well-documented reports of HIV, hepatitis C virus, or hepatitis D virus transmission during sport. There is also no evidence for universal testing for BBPs as a specific requirement for participation in sports. Competitive athletes and nonathletes should follow appropriate general public health agency recommendations for screening for BBPs, considering their individual risk factors and exposures. Standard (universal) precautions must be followed by those providing care to athletes. Exercise and athletic participation can help promote a healthy lifestyle for persons living with BBPs. Those with acute symptomatic BBP infection should limit exercise intensity based on their current health status. Education is the key tool for preventing BBP transmission. Research gaps include evaluation of the prevalence of BBP infections in competitive athletes, the effects of long-term, intense training on infected athletes, and the effects of BBP treatment therapies on performance.

AMSSM position statement update: blood-borne pathogens in the context of sports participation

This American Medical Society for Sports Medicine position statement update is directed towards healthcare providers of patients involved in sport and exercise. There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), and this update incorporates these advancements. This document is intended as a general guide to clinical practice based on the current state of the evidence, while acknowledging the need for modification as new knowledge becomes available. Confirmed transmission of BBPs during sport is exceedingly rare. There are no well-documented reports of HIV, HCV or HDV transmission during sport. There is also no evidence for universal testing for BBPs as a specific requirement for participation in sports. Competitive athletes and non-athletes should follow appropriate general public health agency recommendations for screening for BBPs, considering their individual risk factors and exposures. Standard (universal) precautions must be followed by those providing care to athletes. Exercise and athletic participation can help promote a healthy lifestyle for persons living with BBPs. Those with acute symptomatic BBP infection should limit exercise intensity based on their current health status. Education is the key tool for preventing BBP transmission. Research gaps include evaluation of the prevalence of BBP infections in competitive athletes, the effects of long-term, intense training on infected athletes and the effects of BBP treatment therapies on performance.